Download PDF
CC BY-NC-ND 4.0 · Avicenna J Med 2015; 05(02): 42-45
DOI: 10.4103/2231-0770.154197
CASE REPORT

Extensive vascular occlusions as initial presentations of systemic lupus erythematosis. A case report and review of literature

Mohamed A Elsharawy
Department of General Surgery (Vascular Division), University of Dammam, Dammam, Saudi Arabia
,
Manal Hasan
Department of Internal Medicine, University of Dammam, Dammam, Saudi Arabia
,
Ibrahiem Saeed Abdul-Rahman
Department of Internal Medicine, University of Dammam, Dammam, Saudi Arabia
,
Bandar Al-Dhofairy
Department of Radiology, University of Dammam, Dammam, Saudi Arabia
,
Ayman Elsaid
Department of General Surgery (Vascular Division), University of Dammam, Dammam, Saudi Arabia
› Author Affiliations
› Further Information
  PDF Download Permissions and Reprints

Abstract

Widespread arterial and venous thrombosis is a very rare initial presentation of systemic lupus erythematosus (SLE). We report a case with extensive vascular occlusion as the initial manifestation of SLE. Although these cases have high morbidity and mortality, yet our patient recovered with minimal complications.

Keywords

Catastrophic anti-phospholipid syndrome - systemic lupus erythematosus - vascular thrombosis


Publication History

Article published online:
09 August 2021

© 2015. Syrian American Medical Society. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Burgos PI, McGwin G Jr, Reveille JD, Vilá LM, Alarcón GS. Factors predictive of thrombotic events in LUMINA, a multi-ethnic cohort of SLE patients (LXXII). Rheumatology 2010;9:1720-5.
  • 2 Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012;64:2677-86.
  • 3 Gustafsson JT, Simard JF, Gunnarsson I, Elvin K, Lundberg IE, Hansson LO, et al. Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study. Arthritis Res Ther 2012;14:R46.
  • 4 Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa MC, Piette JC, et al. Catastrophic Antiphospholipid Syndrome Registry Project Group. Catastrophic antiphospholipid syndrome: International consensus statement on classification criteria and treatment guidelines. Lupus 2003;12:530-4.
  • 5 Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45:S5-67.
  • 6 Bjornadal L, Yin L, Granath F, Klareskog L, Ekbom A. Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: Results from a Swedish population based study. J Rheumatol 2004;31:713-9.
  • 7 da Rocha MC, Vilar MJ, Freire EA, Santiago MB. Arterial occlusion in systemic lupus erythematosus: A good prognostic sign? Clin Rheumatol 2005;24:602-5.
  • 8 Dubois EL, Tuffanelli DL. Clinical manifestations of systemic lupus erythematosus. Computer analysis of 520 cases. JAMA 1964;190:104-11.
  • 9 Kwon SU, Koh JY, Kim JS. Vertebrobasilar artery territory infarction as an initial manifestation of systemic lupus erythematosus. Clin Neurol Neurosurg 1999;101:62-7.
  • 10 Asherson RA, Cervera R. Catastrophic antiphospholipid syndrome. Curr Rheumatol Rep 2003;5:395-400.
  • 11 Theodoridou A, Bento L, D′Cruz DP, Khamashta MA, Hughes GR. Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythematosus: A pilot study. Ann Rheum Dis 2003;62:1199-203.
  • 12 Asherson RA, Cervera R, Klumb E, Stojanovic L, Sarzi-Puttini P, Yinh J, et al. Amputation of digits or limbs in patients with antiphospholipid syndrome. Semin Arthritis Rheum 2008;38:124-31.
  • 13 Mitsias P, Levine SR. Large cerebral vessel occlusive disease in systemic lupus erythematosus. Neurology 1994;44:385-93.
  • 14 Wang CR, Chou CC, Hsieh KH, Chuang CY, Chen CY. Lupus patients with peripheral vascular thrombosis: The significance of measuring anticardiolipin antibody. Am J Emerg Med 1993;11:468-70.
  • 15 Hashimoto H, Maekawa S, Nasu H, Okada T, Shiokawa Y, Fukuda Y. Systemic vascular lesions and prognosis in systemic lupus erythematosus. Scand J Rheumatol 1984;13:45-55.
  • 16 Lazúrová I, Benhatchi K. Autoimmune thyroid diseases and nonorganspecific autoimmunity. Pol Arch Med Wewn 2012;122:55-9.
  • 17 Bucciarelli S, Cervera R, Espinosa G, Gómez-Puerta JA, Ramos-Casals M, Font J. Mortality in the catastrophic antiphospholipid syndrome: Causes of death and prognostic factors. Autoimmun Rev 2006;6:72-5.